Hideyuki Abe
Papers
1
Total Citations
12
H-Index
1
About
Dr. Hideyuki Abe is a distinguished urologic oncologist whose research focuses on improving surgical outcomes and risk stratification for prostate cancer patients, particularly those undergoing robot-assisted radical prostatectomy. His work centers on refining predictive models using clinical and pathological markers, such as prostate-specific antigen density and detailed biopsy core characteristics, to better forecast oncological outcomes in intermediate to high-risk cases. Notably, his most-cited study (2017, 12 citations) demonstrates how integrating biopsy core details with PSA density can guide surgical decision-making, potentially reducing overtreatment and enhancing precision in lymph node dissection. Dr. Abe’s contributions address a critical gap in urologic oncology—balancing cancer control with quality of life—by providing evidence-based tools for personalized surgical planning. His research is highly regarded for its practical implications, helping surgeons identify patients who may benefit from extended resections. With a career dedicated to advancing minimally invasive techniques and risk-adapted therapies, Dr. Abe continues to shape best practices in prostate cancer management, making his work essential reading for clinicians and researchers striving to optimize outcomes in high-risk populations.
Research Focus
Key Achievements
Top Papers
- 1